Literature DB >> 16979174

Diabetic atherosclerosis mouse models.

Kenneth K Wu1, Youming Huan.   

Abstract

Coronary heart disease (CHD) due to atherosclerosis is the leading cause of death in the USA, and accelerated CHD has emerged as a leading cause of morbidity and mortality in diabetic patients in the USA and worldwide. This has highlighted the importance and urgency of studying the mechanism of diabetic atherosclerosis and exploring therapeutic options. Due to its unique advantages over other animal models, the mouse is the most used model for studying the mechanism of diabetes-accelerated atherosclerosis and exploring effective therapeutic approaches. In the past decade, several diabetic atherosclerosis mouse models have been established. Currently, however, there is no ideal animal model for diabetic atherosclerosis. To determine the characteristics of the models that more closely resemble human diabetic atherosclerosis disease, this review focuses on the common diabetic atherosclerosis mouse models with respect to the following issues: (1) whether the mice retain diabetic condition; (2) whether the diabetes accelerates atherosclerosis or increases atherogenic inflammation; (3) whether these factors respond to medical interventions. The discussion is aimed at identifying different diabetic mouse models and their features, in order to heighten awareness of the appropriate models that may provide useful tools for studying the mechanism of diabetes-accelerated atherosclerosis and evaluating therapeutic options.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16979174     DOI: 10.1016/j.atherosclerosis.2006.08.030

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  41 in total

1.  Hyperglycemia limits experimental aortic aneurysm progression.

Authors:  Noriyuki Miyama; Monica M Dua; Janice J Yeung; Geoffrey M Schultz; Tomoko Asagami; Eiketsu Sho; Mien Sho; Ronald L Dalman
Journal:  J Vasc Surg       Date:  2010-08-03       Impact factor: 4.268

2.  Glycosphingolipids promote pro-atherogenic pathways in the pathogenesis of hyperglycemia-induced accelerated atherosclerosis.

Authors:  Vi T Dang; Lexy H Zhong; Aric Huang; Arlinda Deng; Geoff H Werstuck
Journal:  Metabolomics       Date:  2018-07-03       Impact factor: 4.290

3.  Spontaneously diabetic Ins2(+/Akita):apoE-deficient mice exhibit exaggerated hypercholesterolemia and atherosclerosis.

Authors:  John Y Jun; Zhexi Ma; Lakshman Segar
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-03-29       Impact factor: 4.310

Review 4.  Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease.

Authors:  Rai Ajit K Srivastava
Journal:  Mol Cell Biochem       Date:  2017-08-21       Impact factor: 3.396

5.  Immune activation resulting from NKG2D/ligand interaction promotes atherosclerosis.

Authors:  Mingcan Xia; Nadia Guerra; Galina K Sukhova; Kangkang Yang; Carla K Miller; Guo-Ping Shi; David H Raulet; Na Xiong
Journal:  Circulation       Date:  2011-11-21       Impact factor: 29.690

6.  Activation of vascular bone morphogenetic protein signaling in diabetes mellitus.

Authors:  Kristina I Boström; Medet Jumabay; Aleksey Matveyenko; Susanne B Nicholas; Yucheng Yao
Journal:  Circ Res       Date:  2010-12-30       Impact factor: 17.367

7.  Accelerated atherosclerosis in Apoe-/- mice heterozygous for the insulin receptor and the insulin receptor substrate-1.

Authors:  Elena V Galkina; Matthew Butcher; Susanna R Keller; Matthew Goff; Anthony Bruce; Hong Pei; Ian J Sarembock; John M Sanders; Melissa H Nagelin; Suseela Srinivasan; Rohit N Kulkarni; Catherine C Hedrick; Frank A Lattanzio; Anca D Dobrian; Jerry L Nadler; Klaus Ley
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-12-22       Impact factor: 8.311

8.  Hyperglycemia modulates plasminogen activator inhibitor-1 expression and aortic diameter in experimental aortic aneurysm disease.

Authors:  Monica M Dua; Noriyuki Miyama; Junya Azuma; Geoffrey M Schultz; Mien Sho; John Morser; Ronald L Dalman
Journal:  Surgery       Date:  2010-06-19       Impact factor: 3.982

9.  Endothelial-mesenchymal transition in atherosclerotic lesion calcification.

Authors:  Kristina I Boström; Jiayi Yao; Pierre J Guihard; Ana M Blazquez-Medela; Yucheng Yao
Journal:  Atherosclerosis       Date:  2016-09-02       Impact factor: 5.162

Review 10.  Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies.

Authors:  Theodore Mazzone; Alan Chait; Jorge Plutzky
Journal:  Lancet       Date:  2008-05-24       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.